Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/PHARNEXT-SCA-29750723/news/Pharnext-Announces-First-Patient-Enrolled-in-the-PREMIER-Trial-its-Pivotal-Phase-III-Clinical-Dev-32845886/?utm_source=whatsapp&utm_medium=social&utm_campaign=share